Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]    
Revenues $ 6,271,000 $ 4,499,000
Cost of sales 4,933,000 3,626,000
Gross profit 1,338,000 873,000
Operating expenses:    
Selling and administrative 3,498,000 2,920,000
Research and development 1,967,000 1,507,000
Total operating expenses 5,465,000 4,427,000
Operating loss (4,127,000) (3,554,000)
Interest expense (3,000) (430,000)
Net loss $ (4,130,000) $ (3,984,000)
Net loss per share - basic and diluted $ (0.30) $ (0.42)
Weighted average number of common shares outstanding - basic and diluted 13,804,475 9,536,441